More than 40 cell and gene therapy companies call Philadelphia home. Their work is facilitated by academic/industrial partnerships with world-class scientists at Children’s Hospital of Philadelphia (CHOP), Temple University, Drexel University, and University of Pennsylvania. Led by Wilson, UPenn’s Gene Therapy Program has been a particularly strong catalyst of the growth that led to $3 billion in investment in cell and gene therapies (CGT) in 2021.
Biosimilars, also known as follow-on biologics, continued to capture greater market share and foment stronger competition with reference or brand name drugs in 2021. Increasing the number of biosimilars in the market and amplifying uptake by payers, family medical practices and pharmacies could be a gamechanger for patients and a healthcare system trying to reduce the cost of life-changing medicines.
Governor Larry Hogan joined dozens of attendees at Ellume’s grand opening in Frederick on March 31 to welcome the diagnostics manufacturer to Frederick County. Ellume’s 215,000-square-foot production facility on Executive Way has been up and running since February 2022, only ten months after the company signed a lease with Matan Properties.
As of this week, there’s been heavy reporting that the Biden Administration has prepared new guidance on digital assets that could be released at any moment. Most of these reports suggest that the guidance will be centered around directing government agencies to study the potential benefits of Central Bank Digital Currencies (CBDCs), or tokenized versions of the US Dollar ($USD). These CBDCs have the capability to be minted on-demand and are programmable based on monetary policy set by the Federal Reserve and other entities. There’s other uses when paired with other digital assets that have the potential to improve and modernize the global financial system.
Secretary of Commerce tours new I-270 Innovation Labs, flexible lab space meeting critical industry need
From left to right: Kelly Shultz – Secretary of Commerce, State of Maryland; Luis Rugeles – Co-founder & CEO, I-270 Innovation Labs; and Doug Bane – Co-founder & COO, I-270 Innovation Labs.
The growing life sciences ecosystem in Maryland has become a shining star in the BioHealth Capital Region. The region has seen explosive growth driven by billions of federal dollars aimed at R&D efforts to combat the COVID-19 threat. And that continued growth has become a magnet for a robust supply of life sciences talent that will continue to shape the future of the state and region.
Milken Institute Report Highlights How Maryland is Growing one of the Nation’s Strongest Life Science Ecosystems
Home to an array of renowned universities, federal labs, and government resources, it’s no surprise that the globally renowned Milken Institute found that Maryland “has one of the nation’s strongest life sciences industries,” according to its recent report.
It’s clear that Maryland’s efforts to grow its recognition as a life sciences/biotech hub have paid off. However, there is still more work to be done in order for Maryland’s R&D growth trajectory to keep up with other leading hubs such as Massachusetts and North Carolina.
Philadelphia’s soaring life sciences commercial real estate market is being driven by the combination of strong demand for advanced lab and manufacturing facilities and near record low vacancy rates.
Virginia Beach is seeking to build a bio cluster in the heart of everything Virginia Beach has to offer. The cluster reached an important milestone, recently opening a brand new accelerator lab constructed and managed by BioHealth Capital Region (BHCR) stalwart Facility Logix. VABeachBio and its partners see this new lab as a sign of great things to come.
Its Women’s History Month and being on the heels of Black History Month, BioBuzz is highlighting three successful black women in industry to straddle the importance of both.